Nasdaq 5,000: The cure or curse for biotech stocks By: CNBC.com News February 27, 2015 at 13:19 PM EST In the Nasdaq composite, financial, consumer services and health-care sectors have seen their weightings more than double. Read More >> Related Stocks: Apple Gilead Sciences Nasdaq Biotechnology Ishares ETF PowerShares QQQ